Oric Pharmaceuticals, Inc.

( )
ORIC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.46%38.340.9%$1224.56m
JNJJohnson & Johnson 1.80%149.620.7%$883.79m
MRKMerck & Co., Inc. 2.26%82.740.7%$648.59m
BMYBristol-Myers Squibb Co. 0.81%63.641.0%$648.38m
ABBVAbbVie, Inc. 3.11%95.551.9%$626.64m
AZNAstraZeneca Plc 2.85%56.751.2%$571.06m
LLYEli Lilly & Co. 1.32%152.621.1%$419.73m
NVSNovartis AG 3.02%84.920.2%$146.41m
GSKGlaxoSmithKline Plc 2.12%42.170.2%$139.29m
MISTMilestone Pharmaceuticals, Inc. -1.12%8.800.0%$120.75m
OPKOPKO Health, Inc. -5.03%4.7211.2%$111.10m
NVONovo Nordisk A/S 2.92%67.090.1%$72.27m
RGENRepligen Corp. 0.66%142.937.2%$67.22m
PRNBPrincipia Biopharma, Inc. 3.78%87.340.0%$58.45m
SNYSanofi 1.91%51.790.2%$57.22m

Company Profile

Oric Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.